Real-world treatment patterns and outcomes beyond first-line immune checkpoint inhibition in patients with HCC: Interim results from the prospective national intersectoral cohort study JADE.

15. Januar 2026

Schröder J., Berg T., Schultheiß M., Müller T., Galle P.R., Kreher S., Gärtner M., Kubisch I., Schulze M., Bürkle D., Siebenbach H.U., Spring L., Weinberg F., Jänicke M., Hofmann W.P., Pereira P.L., Thimme R., Potthoff K., JADE Registry Group.

Oncol Res Treat (2025) 48 (Suppl. 2): 4–364.

Poster